SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-339389
Filing Date
2021-11-24
Accepted
2021-11-24 07:50:58
Documents
12
Period of Report
2021-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d222550d8k.htm   iXBRL 8-K 23956
  Complete submission text file 0001193125-21-339389.txt   142388

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA teva-20211122.xsd EX-101.SCH 2895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20211122_lab.xml EX-101.LAB 17306
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20211122_pre.xml EX-101.PRE 10931
5 EXTRACTED XBRL INSTANCE DOCUMENT d222550d8k_htm.xml XML 3422
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 211441268
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences